Deciphera Pharmaceuticals
Earnings Date & Report
Last updated:
Deciphera Pharmaceuticals’s last earnings date was on 5 Feb 2024.
Deciphera Pharmaceuticals stock Earnings report, Estimates & History
| 2019-08-02 | -0.2833 | -0.56 |
|---|---|---|
| 2019-11-04 | -1.44038 | -1.28 |
| 2020-03-09 | -1.45633 | -1.31 |
| 2020-05-05 | -1.47383 | -1.36 |
| 2020-08-04 | -1.05336 | -1.2 |
| 2020-11-05 | -0.98287 | -1.13 |
| 2021-02-09 | -1.0505 | -1.1 |
| 2021-05-04 | -1.05661 | -1.06 |
| 2021-08-03 | -1.2676 | -1.21 |
| 2021-11-02 | -1.47097 | -1.37 |
| 2022-02-08 | -1.6533 | -1.51 |
| 2022-05-04 | -0.7104 | -0.8 |
| 2022-08-04 | -0.54714 | -0.6 |
| 2022-11-03 | -0.52486 | -0.55 |
| 2023-02-07 | -0.64566 | -0.6 |
| 2023-05-03 | -0.6 | -0.6 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Deciphera Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 5 Feb 2024 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 1 Nov 2023 | N/A | N/A | N/A | N/A | N/A | |
| 2 Aug 2023 | N/A | -$0.6 | N/A | 36.47M | N/A | |
| 3 May 2023 | Matched | -$0.6 | -$0.6 | 35.8M | 33.44M | |
| 7 Feb 2023 | Beat | -$0.65 | -$0.6 | 35.48M | 36.34M | Earnings Call Transcript |
| 31 Dec 2022 | N/A | N/A | -$0.6 | N/A | 36.34M | |
| 3 Nov 2022 | Missed | -$0.52 | -$0.55 | N/A | 35.97M | |
| 4 Aug 2022 | Missed | -$0.55 | -$0.6 | N/A | 32.49M | |
| 4 May 2022 | Missed | -$0.71 | -$0.8 | 32.47M | 29.22M | |
| 8 Feb 2022 | Beat | -$1.65 | -$1.51 | 23.29M | 24.19M | Earnings Call Transcript |
| 2 Nov 2021 | Beat | -$1.47 | -$1.37 | 22.6M | 23.22M | Earnings Call Transcript |
| 3 Aug 2021 | Beat | -$1.27 | -$1.21 | 23.57M | 23.57M | Earnings Call Transcript |
| 4 May 2021 | Missed | -$1.06 | -$1.06 | 21.74M | 25.15M | |
| 9 Feb 2021 | Missed | -$1.05 | -$1.1 | 20.33M | 19.48M | Earnings Call Transcript |
| 5 Nov 2020 | Missed | -$0.98 | -$1.13 | 9.54M | 15.44M | |
| 4 Aug 2020 | Missed | -$1.05 | -$1.2 | 8.09M | 7.09M | Earnings Call Transcript |
| 5 May 2020 | Beat | -$1.47 | -$1.36 | 56.98K | 62K | |
| 9 Mar 2020 | Beat | -$1.46 | -$1.31 | N/A | N/A | Earnings Call Transcript |
| 4 Nov 2019 | Beat | -$1.44 | -$1.28 | N/A | N/A | Earnings Call Transcript |
| 2 Aug 2019 | Missed | -$0.28 | -$0.56 | 49.55M | 25M | |
Deciphera Pharmaceuticals Earnings report FAQs
When is Deciphera Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Deciphera Pharmaceuticals's earnings date was on 7 Feb 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.